vs
Park Hotels & Resorts Inc.（PK）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Park Hotels & Resorts Inc.的季度营收约是Royalty Pharma plc的1.0倍（$629.0M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs -32.6%，领先67.0%），Royalty Pharma plc同比增速更快（4.8% vs 0.6%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -0.8%）
Park Hotels & Resorts是一家总部位于美国弗吉尼亚州泰森斯的房地产投资信托（REIT），核心业务为酒店物业投资运营。该企业于2017年从希尔顿全球集团分拆成立，在酒店不动产领域拥有专业的投资与管理经验。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
PK vs RPRX — 直观对比
营收规模更大
PK
是对方的1.0倍
$622.0M
营收增速更快
RPRX
高出4.1%
0.6%
净利率更高
RPRX
高出67.0%
-32.6%
两年增速更快
RPRX
近两年复合增速
-0.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $629.0M | $622.0M |
| 净利润 | $-205.0M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | -26.1% | 62.4% |
| 净利率 | -32.6% | 34.4% |
| 营收同比 | 0.6% | 4.8% |
| 净利润同比 | -410.6% | 2.9% |
| 每股收益（稀释后） | $-1.04 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PKRPRX
| Q4 25 | $629.0M | $622.0M | ||
| Q3 25 | $610.0M | $609.3M | ||
| Q2 25 | $672.0M | $578.7M | ||
| Q1 25 | $630.0M | $568.2M | ||
| Q4 24 | $625.0M | $593.6M | ||
| Q3 24 | $649.0M | $564.7M | ||
| Q2 24 | $686.0M | $537.3M | ||
| Q1 24 | $639.0M | $568.0M |
净利润PKRPRX
| Q4 25 | $-205.0M | $214.2M | ||
| Q3 25 | $-16.0M | $288.2M | ||
| Q2 25 | $-5.0M | $30.2M | ||
| Q1 25 | $-57.0M | $238.3M | ||
| Q4 24 | $66.0M | $208.2M | ||
| Q3 24 | $54.0M | $544.0M | ||
| Q2 24 | $64.0M | $102.0M | ||
| Q1 24 | $28.0M | $4.8M |
营业利润率PKRPRX
| Q4 25 | -26.1% | 62.4% | ||
| Q3 25 | 9.7% | 70.1% | ||
| Q2 25 | 9.7% | 36.3% | ||
| Q1 25 | 1.1% | 94.0% | ||
| Q4 24 | 13.3% | 60.9% | ||
| Q3 24 | 14.6% | — | ||
| Q2 24 | 17.6% | 50.2% | ||
| Q1 24 | 14.4% | -13.0% |
净利率PKRPRX
| Q4 25 | -32.6% | 34.4% | ||
| Q3 25 | -2.6% | 47.3% | ||
| Q2 25 | -0.7% | 5.2% | ||
| Q1 25 | -9.0% | 41.9% | ||
| Q4 24 | 10.6% | 35.1% | ||
| Q3 24 | 8.3% | 96.3% | ||
| Q2 24 | 9.3% | 19.0% | ||
| Q1 24 | 4.4% | 0.8% |
每股收益（稀释后）PKRPRX
| Q4 25 | $-1.04 | $0.49 | ||
| Q3 25 | $-0.08 | $0.67 | ||
| Q2 25 | $-0.02 | $0.07 | ||
| Q1 25 | $-0.29 | $0.55 | ||
| Q4 24 | $0.32 | $0.46 | ||
| Q3 24 | $0.26 | $1.21 | ||
| Q2 24 | $0.30 | $0.23 | ||
| Q1 24 | $0.13 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $232.0M | $618.7M |
| 总债务越低越好 | $3.9B | $9.0B |
| 股东权益账面价值 | $3.1B | $9.7B |
| 总资产 | $7.7B | $19.6B |
| 负债/权益比越低杠杆越低 | 1.23× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资PKRPRX
| Q4 25 | $232.0M | $618.7M | ||
| Q3 25 | $278.0M | $938.9M | ||
| Q2 25 | $319.0M | $631.9M | ||
| Q1 25 | $233.0M | $1.1B | ||
| Q4 24 | $402.0M | $929.0M | ||
| Q3 24 | $480.0M | $950.1M | ||
| Q2 24 | $449.0M | $1.8B | ||
| Q1 24 | $378.0M | $843.0M |
总债务PKRPRX
| Q4 25 | $3.9B | $9.0B | ||
| Q3 25 | $3.9B | $8.9B | ||
| Q2 25 | $3.9B | $8.0B | ||
| Q1 25 | $3.9B | $7.6B | ||
| Q4 24 | $3.9B | $7.6B | ||
| Q3 24 | $3.9B | $7.6B | ||
| Q2 24 | $3.9B | $7.6B | ||
| Q1 24 | $3.8B | $6.1B |
股东权益PKRPRX
| Q4 25 | $3.1B | $9.7B | ||
| Q3 25 | $3.4B | $9.6B | ||
| Q2 25 | $3.4B | $9.5B | ||
| Q1 25 | $3.5B | $9.8B | ||
| Q4 24 | $3.6B | $10.3B | ||
| Q3 24 | $3.8B | $10.3B | ||
| Q2 24 | $3.8B | $9.8B | ||
| Q1 24 | $3.8B | $9.9B |
总资产PKRPRX
| Q4 25 | $7.7B | $19.6B | ||
| Q3 25 | $8.8B | $19.3B | ||
| Q2 25 | $8.9B | $18.3B | ||
| Q1 25 | $8.9B | $17.6B | ||
| Q4 24 | $9.2B | $18.2B | ||
| Q3 24 | $9.2B | $18.0B | ||
| Q2 24 | $9.2B | $17.7B | ||
| Q1 24 | $9.1B | $16.1B |
负债/权益比PKRPRX
| Q4 25 | 1.23× | 0.92× | ||
| Q3 25 | 1.14× | 0.93× | ||
| Q2 25 | 1.12× | 0.84× | ||
| Q1 25 | 1.11× | 0.78× | ||
| Q4 24 | 1.06× | 0.74× | ||
| Q3 24 | 1.03× | 0.74× | ||
| Q2 24 | 1.03× | 0.78× | ||
| Q1 24 | 1.00× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $105.0M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $-3.0M | — |
| 自由现金流率自由现金流/营收 | -0.5% | — |
| 资本支出强度资本支出/营收 | 17.2% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | $102.0M | — |
8季度趋势，按日历期对齐
经营现金流PKRPRX
| Q4 25 | $105.0M | $827.1M | ||
| Q3 25 | $99.0M | $702.6M | ||
| Q2 25 | $108.0M | $364.0M | ||
| Q1 25 | $86.0M | $596.1M | ||
| Q4 24 | $80.0M | $742.5M | ||
| Q3 24 | $140.0M | $703.6M | ||
| Q2 24 | $117.0M | $658.2M | ||
| Q1 24 | $92.0M | $664.6M |
自由现金流PKRPRX
| Q4 25 | $-3.0M | — | ||
| Q3 25 | $31.0M | — | ||
| Q2 25 | $65.0M | — | ||
| Q1 25 | $9.0M | — | ||
| Q4 24 | $17.0M | — | ||
| Q3 24 | $97.0M | — | ||
| Q2 24 | $66.0M | — | ||
| Q1 24 | $22.0M | — |
自由现金流率PKRPRX
| Q4 25 | -0.5% | — | ||
| Q3 25 | 5.1% | — | ||
| Q2 25 | 9.7% | — | ||
| Q1 25 | 1.4% | — | ||
| Q4 24 | 2.7% | — | ||
| Q3 24 | 14.9% | — | ||
| Q2 24 | 9.6% | — | ||
| Q1 24 | 3.4% | — |
资本支出强度PKRPRX
| Q4 25 | 17.2% | — | ||
| Q3 25 | 11.1% | — | ||
| Q2 25 | 6.4% | — | ||
| Q1 25 | 12.2% | — | ||
| Q4 24 | 10.1% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 7.4% | — | ||
| Q1 24 | 11.0% | — |
现金转化率PKRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | 1.21× | 3.57× | ||
| Q3 24 | 2.59× | 1.29× | ||
| Q2 24 | 1.83× | 6.45× | ||
| Q1 24 | 3.29× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PK
| Occupancy | $371.0M | 59% |
| Food And Beverage | $173.0M | 28% |
| Ancillary Hotel | $61.0M | 10% |
| Hotel Other | $24.0M | 4% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
